Mostrar el registro sencillo del ítem

dc.contributor.authorde Mendoza, Carmen
dc.contributor.authorPérez, Leire
dc.contributor.authorFernández-Ruiz, Mario
dc.contributor.authorPena, María José
dc.contributor.authorRamos, José Manuel
dc.contributor.authorRichart, Alberto
dc.contributor.authorPiron, María
dc.contributor.authorRando, Ariadna
dc.contributor.authorMiró, Elisenda
dc.contributor.authorReina, Gabriel
dc.contributor.authorEncinas, Beatriz
dc.contributor.authorRojo, Silvia
dc.contributor.authorRodríguez Iglesias, Manuel Antonio 
dc.contributor.authorBenito, Rafael
dc.contributor.authorAguilera, Antonio
dc.contributor.authorTreviño, Ana
dc.contributor.authorCorral, Octavio
dc.contributor.authorSoriano, Vicente
dc.contributor.otherBiomedicina, Biotecnología y Salud Públicaes_ES
dc.date.accessioned2023-02-23T12:08:32Z
dc.date.available2023-02-23T12:08:32Z
dc.date.issued2022-09
dc.identifier.issn1201-9712
dc.identifier.urihttp://hdl.handle.net/10498/28007
dc.description.abstractObjectives: Although only 10% of persons infected with human T-lymphotropic virus type 1 (HTLV-1) may develop virus-associated illnesses over their lifetime, missing the earlier diagnosis of asymptomatic carriers frequently leads to late presentation. Methods: A nationwide HTLV-1 register was created in Spain in 1989. We examined the main demographics and clinical features at the time of the first diagnosis for more than three decades. Results: A total of 428 individuals infected with HTLV-1 had been reported in Spain until the end of 2021. Up to 96 (22%) individuals presented clinically with HTLV-1-associated conditions, including subacute myelopathy (57%), T-cell lymphoma (34%), or Strongyloides stercoralis infestation (8%). Since 2008, HTLV-1 diagnosis has been made at blood banks (44%) or clinics (56%). Native Spaniards and Sub-Saharan Africans are overrepresented among patients presenting with HTLV-1-associated illnesses suggesting that poor epidemiological and/or clinical suspicion, which led to the late presentation are more frequent in them than carriers from Latin America (LATAM) (31.7% vs 20.4%, respectively; P = 0.015). Conclusion: HTLV-1 infection in Spain is frequently diagnosed in patients presenting with characteristic illnesses. Although screening in blood banks mostly identifies asymptomatic carriers from LATAM, a disproportionately high number of Spaniards and Africans are diagnosed too late at the time of clinical manifestations. Expanding testing to all pregnant women and clinics for sexually transmitted infections could help to unveil HTLV-1 asymptomatic carriers. (c) 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )es_ES
dc.formatapplication/pdfes_ES
dc.language.isoenges_ES
dc.publisherELSEVIERes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceInternational Journal of Infectious Diseases Volume 122, September 2022, Pages 970-975es_ES
dc.subjectHTLV-1es_ES
dc.subjectMyelopathy Diagnosises_ES
dc.subjectLate presentationes_ES
dc.subjectSexually transmitted infectionses_ES
dc.titleLate presentation of human T-lymphotropic virus type 1 infection in Spain reflects suboptimal testing strategieses_ES
dc.typejournal articlees_ES
dc.rights.accessRightsopen accesses_ES
dc.identifier.doi10.1016/j.ijid.2022.07.043
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PI21%2F01717/ES/¿DEBEMOS INCLUIR EL HTLV-1 EN EL LISTADO DE INFECCIONES DE TRANSMISION SEXUAL?/es_ES


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Esta obra está bajo una Licencia Creative Commons Atribución 4.0 Internacional